Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol
スポンサーリンク
概要
- 論文の詳細を見る
- 2013-07-30
著者
-
Shiraki Masataka
Research Institute And Practice For Involutional Disease
-
FUKUNAGA Masao
Kawasaki Medical School
-
MATSUMOTO Toshio
University of Tokushima Graduate School of Medical Sciences
-
TAKANO Toshiyuki
Chugai Pharmaceutical Co. Ltd
-
NAKAMURA Toshitaka
National Center for Global Health and Medicine
関連論文
- Association of a single nucleotide polymorphism in the constitutive androstane receptor gene with bone mineral density
- Association of a Sequence Variation in the Gene Encoding Adiponectin Receptor 1 (ADIPOR1) with Body Mass Index in the Japanese Population
- Association of a single nucleotide polymorphism in the steroid and xenobiotic receptor (SXR) gene (IVS1-579A/G) with bone mineral density
- Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women
- Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1α-OH-vitamin D_3 (alfacalcidol) for treatment of postmenopausal bone loss
- Association of a single nucleotide polymorphism in the secreted frizzled-related protein 4 (sFRP4) gene with bone mineral density
- Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women
- Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
- Association of a single-nucleotide polymorphism in low-density lipoprotein receptor-related protein 5 gene with bone mineral density
- Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women
- Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss
- A1330V Variant of the Low-density Lipoprotein Receptor-related Protein 5 (LRP5) Gene Decreases Wnt Signaling and Affects the Total Body Bone Mineral Density in Japanese Women
- Association of a single nucleotide polymorphism in Wnt10b gene with bone mineral density
- The sample size required for intervention studies on fracture prevention can be decreased by using a bone resorption marker in the inclusion criteria : prospective study of a subset of the Nagano Cohort, on behalf of the Adequate Treatment of Osteoporosis
- A comparison of incidences of vertebral fracture in Japanese patients with involutional osteoporosis treated with risedronate and etidronate : a randomized, double-masked trial
- Alendronate reduced vertebral fracture risk in postmenopausal Japanese women with osteoporosis : a 3-year follow-up study
- Absolute height reduction and percent height ratio of the vertebral body in incident fracture in Japanese women
- Diagnostic criteria for primary osteoporosis: year 2000 revision
- Association of bone mineral density with a dinucleotide repeat polymorphism at the calcitonin (CT) locus
- Identification of a novel polymorphism of estrogen receptor-α gene that is associated with calcium excretion in urine
- Effects of menatetrenone on the bone and calcium metabolism in osteoporosis: A double-blind placebo-controlled study
- Guidelines on the use of biochemical markers of bone turnover in osteoporosis (2001)
- Association of estrogen receptor β (ESR2) gene polymorphism with blood pressure
- Efficacy and tolerability of once-weekly administration of 17.5mg risedronate in Japanese patients with involutional osteoporosis : a comparison with 2.5-mg once-daily dosage regimen
- Association of Bone Metabolism Regulatory Factor Gene Polymorphisms With Susceptibility to Ossification of the Posterior Longitudinal Ligament of the Spine and Its Severity
- Saccharated Ferric Oxide-Induced Osteomalacia in Japan: Iron-Induced Osteopathy Due to Nephropathy
- Association of HTRA1 promoter polymorphism with spinal disc degeneration in Japanese women
- Validation of the Japanese Osteoporosis Quality of Life Questionnaire
- Bone mass effects of a Smad6 gene polymorphism in Japanese postmenopausal women
- Association of a Single Nucleotide Polymorphism in the Insulin-Like Growth Factor-1 Receptor Gene With Spinal Disc Degeneration in Postmenopausal Japanese Women
- Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study
- PE-011 Plasma Heparin Cofactor II Activity is a Predictor of Morphological Characteristics of Coronary Arteries Diffuse-Narrowing in Patients with Diabetes Mellitus(Angina pectoris, basic/clinical-2, The 71st Annual Scientific Meeting of the Japanese Circ
- Effects of phosphorus-containing calcium preparation (bone meal powder) and calcium carbonate on serum calcium and phosphorus in young and old healthy volunteers: a double-blinded crossover study
- Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis : a randomized prospective study
- A polymorphic variant at the Werner helicase(WRN)gene is associated with bone density, but not spondylosis, in postmenopausal women
- High level of serum undercarboxylated osteocalcin in patients with incident fractures during bisphosphonate treatment
- Association of amino acid variation (Trp64Arg) in the beta3-adrenergic receptor gene with bone mineral density
- Ethnic difference in contribution of alleles of the interleukin-1 receptor antagonist gene to predisposition to osteoporosis
- Effect of 1α-Hydroxyvitamin D_3 on Loss of Bone Mineral Density Immediately after Artificial Menopause
- ASSOCIATION OF ESTROGEN RECEPTOR DINUCLEOTIDE REPEAT POLYMORPHISM WITH OSTEOPOROSIS
- Vitamin D insufficiency defined by serum 25-hydroxyvitamin D and parathyroid hormone before and after oral vitamin D_3 load in Japanese subjects
- Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis
- Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment
- Effect of disuse on bone mineral content, lean mass, and fat mass in osteoarthritic patients
- Bone and Calcium Metabolism in Werner's Syndrome
- Breast arterial calcification and hypertension associated with vertebral fracture
- Three years of treatment with minodronate in patients with postmenopausal osteoporosis
- Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition)
- Diagnostic criteria for primary osteoporosis : year 2012 revision
- Eldecalcitol reduces the risk of severe vertebral fractures and improves the health-related quality of life in patients with osteoporosis
- Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol